Morgan Stanley reiterates Overweight on Atour Lifestyle stock at $45
Corroborated by 2 sources from 2 publishers
africahealth2d ago
TL;DR
Barclays reiterates Overweight rating on ANI Pharmaceuticals stock
Sources
1
Bloomberg Economics
https://www.bloomberg.com/news/articles/2026-03-17/morgan-stanley-says-south-africa-to-stay-on-prolonged-rate-hold
3d ago
2
Investing.com News
https://www.investing.com/news/analyst-ratings/morgan-stanley-upgrades-adecoagro-stock-rating-on-profertil-acquisition-impact-93CH-4564784
3d ago
3
Investing.com News
https://www.investing.com/news/analyst-ratings/morgan-stanley-reiterates-overweight-on-atour-lifestyle-stock-at-45-93CH-4566061
3d ago
4
Investing.com News
https://www.investing.com/news/analyst-ratings/barclays-reiterates-overweight-rating-on-ani-pharmaceuticals-stock-93CH-4568956
2d ago